Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
Go back to Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 0.59 -0.02 (3.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $9.09 | |||
| Open | $0.61 | 52 Week Low | $4.02 | |||
| Day High | $0.64 | P/E | N/A | |||
| Day Low | $0.59 | EPS | $-0.05 | |||
| Volume | 59,230 | |||||
